Myeloproliferative neoplasm epidemiology and demographics: Difference between revisions
| Line 8: | Line 8: | ||
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.<ref name="CDC">Centers for Disease Control and Prevention. WTC Health Program.Myeloid Malignancieshttp://www.cdc.gov/wtc/pdfs/WTCHP_PP_MyeloidMalignancies_02012014.pdf</ref> | The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.<ref name="CDC">Centers for Disease Control and Prevention. WTC Health Program.Myeloid Malignancieshttp://www.cdc.gov/wtc/pdfs/WTCHP_PP_MyeloidMalignancies_02012014.pdf</ref> | ||
===Age=== | ===Age=== | ||
The prevalence of myeloproliferative neoplasm increases with age. | The prevalence of myeloproliferative neoplasm increases with age.<ref name="pmid18443215">{{cite journal| author=Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA et al.| title=Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. | journal=Blood | year= 2008 | volume= 112 | issue= 1 | pages= 45-52 | pmid=18443215 | doi=10.1182/blood-2008-01-134858 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18443215 }} </ref> | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with myeloproliferative neoplasm than females. | Males are more commonly affected with myeloproliferative neoplasm than females.<ref name="pmid18443215">{{cite journal| author=Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA et al.| title=Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. | journal=Blood | year= 2008 | volume= 112 | issue= 1 | pages= 45-52 | pmid=18443215 | doi=10.1182/blood-2008-01-134858 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18443215 }} </ref> | ||
===Race=== | ===Race=== | ||
The prevalence of myeloproliferative neoplasm does not vary by race. | The prevalence of myeloproliferative neoplasm does not vary by race.<ref name="pmid18443215">{{cite journal| author=Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA et al.| title=Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. | journal=Blood | year= 2008 | volume= 112 | issue= 1 | pages= 45-52 | pmid=18443215 | doi=10.1182/blood-2008-01-134858 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18443215 }} </ref> | ||
==References== | ==References== | ||
Revision as of 17:16, 22 October 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm epidemiology and demographics |
|
FDA on Myeloproliferative neoplasm epidemiology and demographics |
|
on Myeloproliferative neoplasm epidemiology and demographics |
|
Myeloproliferative neoplasm epidemiology and demographics in the news |
|
Blogs on Myeloproliferative neoplasm epidemiology and demographics |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Epidemiology and Demographics
Incidence
The incidence of myeloproliferative neoplasm is approximately 7.8 per 100,000 individuals worldwide.[1]
Age
The prevalence of myeloproliferative neoplasm increases with age.[2]
Gender
Males are more commonly affected with myeloproliferative neoplasm than females.[2]
Race
The prevalence of myeloproliferative neoplasm does not vary by race.[2]
References
- ↑ 1.0 1.1 Centers for Disease Control and Prevention. WTC Health Program.Myeloid Malignancieshttp://www.cdc.gov/wtc/pdfs/WTCHP_PP_MyeloidMalignancies_02012014.pdf
- ↑ 2.0 2.1 2.2 Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA; et al. (2008). "Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs". Blood. 112 (1): 45–52. doi:10.1182/blood-2008-01-134858. PMID 18443215.